Skip to content
Application 203774
- Type
- ANDA
- Sponsor
- APOTEX INC
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | PEMETREXED DISODIUM | PEMETREXED DISODIUM | POWDER;INTRAVENOUS | EQ 100MG BASE/VIAL | No | No |
| 002 | PEMETREXED DISODIUM | PEMETREXED DISODIUM | POWDER;INTRAVENOUS | EQ 500MG BASE/VIAL | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 60505-6065 | Pemetrexed | Pemetrexed disodium | Apotex Corp | ANDA | Current |
| 60505-6065 | Pemetrexed | Pemetrexed disodium | Apotex Corp | ANDA | Current |
| 60505-6066 | Pemetrexed | Pemetrexed disodium | Apotex Corp | ANDA | Current |
| 60505-6066 | Pemetrexed | Pemetrexed disodium | Apotex Corp | ANDA | Current |
| 68001-543 | Pemetrexed | Pemetrexed disodium | BluePoint Laboratories | ANDA | Current |
| 68001-544 | Pemetrexed | Pemetrexed disodium | BluePoint Laboratories | ANDA | Current |